Clinical Trial Results TV
October 31, 2017: Dr. David J. Cohen and Dr. C. Michael Gibson Discuss: PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of
Dr. David J. Cohen and Dr. C. Michael Gibson Discuss: PARTNER 2A and SAPIEN 3
Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With
Aortic Stenosis

TBD

[ Download video ]


Video Statistics
0 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 0 total votes.

These statistics are updated nightly. The last update ran on
11-23-2017 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted